Company Filing History:
Years Active: 2025
Title: The Innovations of Stephane L Raeppel
Introduction
Stephane L Raeppel is a notable inventor based in Boucherville, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work focuses on enhancing the efficacy of treatments through novel chemical formulations.
Latest Patents
Stephane holds a patent for a crystalline form of a multi-tyrosine kinase inhibitor, which is detailed as follows: N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (Compound 1). This invention encompasses pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form, and methods of use thereof. He has 1 patent to his name.
Career Highlights
Stephane is currently associated with Mirati Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is instrumental in developing new therapies that can potentially improve patient outcomes.
Collaborations
Stephane collaborates with various professionals in the field, including his coworker Franck Raeppel. Their combined expertise contributes to the advancement of their projects and the overall mission of their organization.
Conclusion
Stephane L Raeppel is a dedicated inventor whose work in pharmaceutical innovation is paving the way for new treatment options. His contributions are vital to the ongoing development of effective therapies in the medical field.